Sponsor pipeline

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-24

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

First posted	Trial	Phase	Status
2026-10-22	NCT07890506 Chidamide Combined With Benmelstobart, Nab-paclitaxel, and SBRT as Second-Line Treatment…	Phase 2	Not Yet Recruiting
2026-10-14	NCT07874204 Equivalence of Electronic vs Paper-based PHES in Diagnosing Hepatic Encephalopathy		Not Yet Recruiting
2026-10-01	NCT07852806 Bone Marrow Mononuclear Cells for the Repair of Severe Maxillofacial Bone Defects		Recruiting

Not charted: 61 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Get alerts when The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.